Q1 2026 Management view "While U.S. academic demand, tariff and currency headwinds have continued to pressure our year-over-year results, we are pleased that our first quarter '26 financial ...

Scientific instrument company Bruker (NASDAQ:BRKR). announced in Q1 CY2026, with sales up 2.7% year on year to $823.4 million ...

In addition to the earnings release we issued earlier today, during today's conference call, we will be referencing a slide presentation that can be downloaded from the Events and Presentations ...

Bruker (BRKR) delivered earnings and revenue surprises of +33.62% and +2.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Bruker (Nasdaq: BRKR) today announced the acquisition of Tornado Spectral Systems Inc., a Canadian company specializing in process Raman instruments, primarily ...

Bruker Spatial Biology, a division of Bruker Corporation (Nasdaq: BRKR) announced today that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient ...

Utah-based Grandeur Peak Global Advisors sold 709,697 shares of Bruker in the third quarter. The estimated position value declined by $29.54 million from the previous period. As of September 30, the ...

In a report released yesterday, Subbu Nambi from Guggenheim maintained a Buy rating on Bruker, with a price target of $50.00. The company’s shares closed yesterday at $42.30. Cl ...

The company’s shares were up 3.92% in pre-market trading following the release, as it reaffirmed its full-year guidance despite ongoing headwinds. The scientific instruments maker posted adjusted ...